Mediclinic to acquire City Centre Clinics Deira and Me’Aisem in Dubai

Under the terms of the agreement, Mediclinic will acquire City Centre Clinic Deira, a large outpatient facility which opened in 2013 with two day-care surgery theatres and 18 medical disciplines, and City Centre Clinic Me’aisem, a smaller community clinic focusing on six core disciplines. The clinics serve strategic geographic locations and could refer higher acuity inpatient cases to existing Mediclinic hospitals and the forthcoming Mediclinic Parkview Hospital. Significant potential also exists to attract additional doctors and over time to grow patient volumes and revenues. The clinics can also be efficiently integrated into Mediclinic’s clinical governance framework, support systems and brand.

Majid Al Futtaim opened City Centre Clinic Deira in 2013 with the aim of providing quality healthcare to its shopping mall visitors as part of its integrated lifestyle offering. Five successful years later, this agreement gives Mediclinic Middle East the opportunity to partner with Majid Al Futtaim in future locations, increasing Mediclinic’s brand recognition within high footfall retail environments, a strategy which has been successfully implemented with existing Mediclinic primary healthcare facilities in other malls.

David Hadley, CEO of Mediclinic Middle East, commented:

“Following the success of existing mall clinics in Dubai, Mediclinic identified an opportunity with Majid Al Futtaim at City Centre Clinics Deira and Me’aisem to build additional presence in some of Dubai’s leading retail and entertainment hubs. The clinics are also ideally situated to refer, where necessary, patients to our existing Mediclinic Welcare Hospital in Al Garhoud and our forthcoming Mediclinic Parkview Hospital in Al Barsha South.  We are extremely proud to be associated with the Majid Al Futtaim brand and are confident that the quality standards of both our organisations complement each other well.”

About Mediclinic International plc

Mediclinic is an international private healthcare services group, established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates.

The Group’s core purpose is to enhance the quality of life.

Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.

Mediclinic comprises 77 hospitals, five sub-acute hospitals, 12 day case clinics and 21 outpatient clinics. Hirslanden operates 18 hospitals, two day case clinics and three outpatient clinics in Switzerland with more than 1 900 inpatient beds; Mediclinic Southern Africa operates 52 hospitals, five sub-acute hospitals and 12 day case clinics with more than 8 500 inpatient beds; and Mediclinic Middle East operates seven hospitals, two day case clinics and 21 outpatient clinics with more than 900 inpatient beds in the United Arab Emirates.

The Company’s primary listing is on the London Stock Exchange (“LSE”) in the United Kingdom, with secondary listings on the JSE Ltd in South Africa and the Namibian Stock Exchange in Namibia.

Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the United Kingdom and listed on the LSE.

For further information, please contact:  

Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations 
ir@mediclinic.com
+44 (0)20 3786 8181 

Media Queries 
Mediclinic Middle East
Peter Menelaou, Chief Marketing Officer 
peter.menelaou@mediclinic.ae
+971 4 449 5136

FTI Consulting
Brett Pollard/Debbie Scott – UK 
+44 (0)20 3727 1000
Sherryn Schooling – South Africa  
+27 (0)21 487 9000